Latest news
{{'2026-06-26T13:01:00Z' | dateFormatFilter}}
Novo Nordisk to showcase new data across its haemophilia portfolio at the ISTH Congress 2026, featuring investigational denecimig
{{'2026-06-11T15:30:50Z' | dateFormatFilter}}
Novo Nordisk A/S: IT Security incident at Novo Nordisk
{{'2026-06-07T21:31:24Z' | dateFormatFilter}}
Novo Nordisk’s CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE program presented at ADA 2026
Stay informed
Stay informed
Be the first one to read our company announcements and press releases. Sign up to Novo Nordisk News.
